Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR goggles calm nerves during heart surgery, study finds

NCT ID NCT07250282

Symptom relief Sponsor: Muhammed Kurt Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether wearing a virtual reality headset during heart device implantation (like pacemakers) could reduce patients' anxiety and pain. 111 adults were randomly assigned to use VR or standard care. The goal was to see if distraction through VR lowers stress and discomfort during the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality headset
What this could lead to
If it works, this could offer a simple, drug-free way to help patients feel calmer and less pain during heart device surgery.
What could go wrong
This is a small, completed study with 111 people. The effect may not be strong or apply to all patients. VR headsets can cause dizziness or discomfort in some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

111 people

The number who actually took part.

Started

Jan 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Age ≥ 18 years * Indication for implantation of a cardiac pacemaker, ICD, or CRT device due to one of the following: * Complete heart block (AV block III°) * Symptomatic bradycardia due to sinus node dysfunction * Tachy-brady syndrome * Atrial fibrillation with slow ventricular rate * Symptomatic bradycardia due to AV block II° type Mobitz * Secondary prevention of sudden cardiac death due to ventricular tachycardia * Primary prevention in patients with heart failure with reduced ejection fraction * Primary prevention in patients with heart failure with reduced ejection fraction and complete left bundle branch block * "Pace and ablate" strategy for therapy-resistant persistent atrial fibrillation * Need to Upgrade to CRT-P due to a high percentage of right ventricular pacing Exclusion Criteria: * Significant language barrier preventing consent or cooperation * severe panic disorder or claustrophobia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder atrial fibrillation Mobitz type II atrioventricular block Pain persistent atrial fibrillation sick sinus syndrome systolic heart failure third-degree atrioventricular block

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Pain

Contacts and locations

Locations

  • West german heart and vascular center, University hospital Essen,

    Essen, North Rhine-Westphalia, 45147, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.